PharVision Advisers’s Euroseas ESEA Stock Holding History

PharVision Advisers’s Portfolio ESEA Stock Details ESEA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,696	Closed	-$366K	–	276
2025 Q4	$366K	Sell	6,696 -1,579	-19%	-$90.7K	0.19%	159
2025 Q3	$493K	Buy	+8,275	New	+$466K	0.28%	26

Other funds holding ESEA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Inspire Investing Meridian, Idaho $1.71B AUM 31.76% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

PharVision Advisers's ESEA Position: Q1 2026 in Review

PharVision Advisers sold out of Euroseas (ESEA) in Q1 2026, closing a stake of 6,696 shares — an estimated $366K sold.

PharVision Advisers first reported a position in ESEA in Q3 2025 and held it in 2 quarters. The position peaked at $493K in Q3 2025. 60 funds tracked by Wall St. Rank hold ESEA as of Q1 2026.

PharVision Advisers reported no remaining Euroseas position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 6,696 Euroseas shares in Q1 2026, an estimated $366K.
PharVision Advisers first reported a position in Euroseas in Q3 2025 and held it in 2 quarters.
PharVision Advisers's Euroseas position peaked at $493K in Q3 2025.
60 funds tracked by Wall St. Rank held Euroseas as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.